Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study.
Li K, Zhao F, Guo Y, Wu Q, Luo S, Zhang J, Li H, Hu S, Wu B, Lin G, Qiu H, Niu B, Sun X, Xu L, Lu J, Du X, Wang Z, Wang X, Kang L, Wang Z, Wang Q, Liu Q, Xiao Y.
Li K, et al. Among authors: wu b, wu q.
BMC Cancer. 2023 Sep 18;23(1):797. doi: 10.1186/s12885-023-11196-4.
BMC Cancer. 2023.
PMID: 37718392
Free PMC article.